Increasingly beleaguered, pharma in general and biopharma in particular still shiver at the edge of the pool of lean operations, watching wistfully as the top performers from other sectors splash happily about

There is general recognition in the Life Sciences sector of the need to change and of the nature of the obstacles to overcome, but not much action.  The lean principles are now well proven and, with effective adaptation to the specific requirements of the pharmaceutical industry, they can be applied with the same succeses.  Nothing should stop pharma and biopharma from jumping into the pool.  Now, the regulators themselves are applying the very principles that underlie 'lean' to their own regulatory approach.  The options are rapidly closing!

In this paper, WCI's Marty Boom reviews the background and looks at some of the practical ways of achieving and entrenching that essential breakthrough to world clss performance that the life science industry so patently needs. 

To read the article in full please click on the pdf. link below:

Lean Compliant Operations in Life Science